Inhibition of FASN (fatty acid synthase) reduces (SFAs) and (MUFAs), regulating the process of including PUFAs into phospholipids (PLs) of mutant KRAS lung cancer cells, and increasing their sensitivity to ferroptosis [89]. Here, FASN is linked to lung cancer.